These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

111 related articles for article (PubMed ID: 16124129)

  • 21. Outcome of Kaposi's sarcoma and graft following discontinuation of immunosuppressive drugs in renal transplant recipients.
    Firoozan A; Hosseini Moghaddam SM; Einollahi B; Pour-Reza-Gholi F; Nafar M; Basiri A; Ebrahimi-Rad R
    Transplant Proc; 2005 Sep; 37(7):3061-4. PubMed ID: 16213305
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Successful treatment with paclitaxel of a visceral relapse of post-transplant Kaposi's sarcoma].
    Harzallah A; Ounissi M; Hajji M; Chargui S; Hedri H; Abderrahim E; Ben Hamida F; Bacha M; Ben Abdallah T
    Nephrol Ther; 2021 Apr; 17(2):132-136. PubMed ID: 33563572
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Successful treatment of a child having generalized Kaposi's sarcoma after living donor liver transplantation with conversion to sirolimus.
    Yuksekkaya HA; Arikan C; Yazici A; Baran M; Aydogdu S; Kilic M
    Pediatr Transplant; 2009 May; 13(3):375-8. PubMed ID: 18452496
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Immunosuppressive drugs and the risk of cancer after organ transplantation.
    Dantal J; Soulillou JP
    N Engl J Med; 2005 Mar; 352(13):1371-3. PubMed ID: 15800234
    [No Abstract]   [Full Text] [Related]  

  • 25. Concurrent Kaposi's sarcoma, tuberculosis, and allograft dysfunction in a renal transplant patient.
    Alshaebi F; Adamu B; Alghareeb W
    Saudi J Kidney Dis Transpl; 2009 Mar; 20(2):270-3. PubMed ID: 19237817
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Anticancer effect of sirolimus in renal allograft recipients with de novo malignancies.
    Boratyńska M; Watorek E; Smolska D; Patrzałek D; Klinger M
    Transplant Proc; 2007 Nov; 39(9):2736-9. PubMed ID: 18021973
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Life-threatening exacerbation of Kaposi's sarcoma after prednisone treatment for immune reconstitution inflammatory syndrome.
    Volkow PF; Cornejo P; Zinser JW; Ormsby CE; Reyes-Terán G
    AIDS; 2008 Mar; 22(5):663-5. PubMed ID: 18317012
    [No Abstract]   [Full Text] [Related]  

  • 28. [Kaposi's sarcoma of the laryngopharynx].
    Zenger VG; Synebogov SV; Kadyrova EV
    Vestn Otorinolaringol; 2002; (5):48-9. PubMed ID: 12524971
    [No Abstract]   [Full Text] [Related]  

  • 29. Complete regression of visceral Kaposi's sarcoma after conversion to sirolimus.
    Mohsin N; Budruddin M; Pakkyara A; Darweesh A; Nayyer M; Amitabh J; Daar AS
    Exp Clin Transplant; 2005 Dec; 3(2):366-9. PubMed ID: 16417445
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Generalized Kaposi's sarcoma after allogenic transplantation of cadaver kidney].
    Nepomniashchaia EM; Gusarev SA; Kirichenko IuG
    Arkh Patol; 2004; 66(6):55-7. PubMed ID: 15648170
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Management of Kaposi's sarcoma. Chemotherapy I.
    Vogel CL
    Antibiot Chemother (1971); 1981; 29():82-7. PubMed ID: 7027912
    [No Abstract]   [Full Text] [Related]  

  • 32. Renal angiomyolipomatosis and Kaposi's sarcoma: a possible link disrupted by sirolimus.
    Stallone G; Infante B; Tartaglia L; Bruno F; Gesualdo L; Grandaliano G
    Intern Emerg Med; 2012 Sep; 7 Suppl 2():S127-9. PubMed ID: 22915080
    [No Abstract]   [Full Text] [Related]  

  • 33. Simultaneous non-Hodgkin's and Kaposi's sarcoma in a renal transplant recipient.
    Guz G; Arican A; Karakayali H; Demirhan B; Bilgin N; Haberal M
    Transplant Proc; 1999 Dec; 31(8):3240-1. PubMed ID: 10616461
    [No Abstract]   [Full Text] [Related]  

  • 34. Conversion to sirolimus in posttransplant renal neoplasms.
    Lopez V; Gutierrez C; Cabello M; Burgos D; Sola E; Gonzalez-Molina M
    Transplant Proc; 2007 Sep; 39(7):2264-6. PubMed ID: 17889158
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The CARI guidelines. Calcineurin inhibitors in renal transplantation: therapeutic drug monitoring.
    Trevillian P;
    Nephrology (Carlton); 2007 Feb; 12 Suppl 1():S57-65. PubMed ID: 17316283
    [No Abstract]   [Full Text] [Related]  

  • 36. Seroprevalence of human herpes virus-8 in renal transplant recipients: a single center study from Iran.
    Ahmadpoor P; Ilkhanizadeh B; Sharifzadeh P; Makhdoomi K; Ghafari A; Nahali A; Yekta Z; Noroozinia F
    Transplant Proc; 2007 May; 39(4):1000-2. PubMed ID: 17524874
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The CARI guidelines. Calcineurin inhibitors in paediatric renal transplantation.
    McTaggart S;
    Nephrology (Carlton); 2007 Feb; 12 Suppl 1():S106-10. PubMed ID: 17316270
    [No Abstract]   [Full Text] [Related]  

  • 38. The role of mTOR inhibitors in the management of posttransplant malignancy.
    Monaco AP
    Transplantation; 2009 Jan; 87(2):157-63. PubMed ID: 19155967
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Salivary human herpesvirus 8 shedding in renal allograft recipients with Kaposi's sarcoma.
    Al-Otaibi LM; Ngui SL; Scully CM; Porter SR; Teo CG
    J Med Virol; 2007 Sep; 79(9):1357-65. PubMed ID: 17607792
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Laryngeal kaposi's sarcoma in a renal-transplant recipient.
    Liao CH; Ko JY; Chueh SC; Lai MK; Chun J
    Transplantation; 2003 Sep; 76(5):884-5. PubMed ID: 14501875
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.